Literature DB >> 8017888

Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.

H Lassmann1, G Suchanek, K Ozawa.   

Abstract

Histopathology of multiple sclerosis is defined by a chronic inflammatory process and the presence of large confluent plaques of demyelination. Ongoing disease activity is due to an active inflammatory process, mainly mediated by T lymphocytes and macrophages, and is associated with blood-brain-barrier damage. B lymphocytes and plasma cells are present especially in the lesions that occur during the late chronic stage of the disease. Although all plaques are characterized by demyelination, the patterns of oligodendroglia destruction and of damage to other tissue elements, such as axons and astrocytes, are variable in different cases. Oligodendrocytes are less affected by plaques that develop during the first bouts of the disease than by those plaques arising after several years of disease duration. Our data indicate that mechanisms of plaque formation may vary in different multiple sclerosis patients and in different stages of the disease process.

Entities:  

Mesh:

Year:  1994        PMID: 8017888     DOI: 10.1002/ana.410360713

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Monocyte-derived cytokines in multiple sclerosis.

Authors:  L G Filion; G Graziani-Bowering; D Matusevicius; M S Freedman
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

3.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

Review 4.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

Review 5.  Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?

Authors:  H Lassmann; K Vass
Journal:  Springer Semin Immunopathol       Date:  1995

6.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

Authors:  C Liu; S Edwards; Q Gong; N Roberts; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

7.  IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS).

Authors:  P Kivisäkk; D Matusevicius; B He; M Söderström; S Fredrikson; H Link
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 8.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 9.  Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.

Authors:  David H Miller
Journal:  NeuroRx       Date:  2004-04

10.  Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation.

Authors:  Jack van Horssen; Shailender Singh; Susanne van der Pol; Markus Kipp; Jamie L Lim; Laura Peferoen; Wouter Gerritsen; Evert-Jan Kooi; Maarten E Witte; Jeroen J G Geurts; Helga E de Vries; Regina Peferoen-Baert; Peter J van den Elsen; Paul van der Valk; Sandra Amor
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.